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Following the demonstration that intracellular expression of antibodies ('intracellular immunization') may be utilized to engineer new traits in mam- 
malian cells [I], we undertook experiments to perturb the function of p21 ras proteins, by engineering the intracellular expression of the anti-p21 r~s
antibody Y13-259 [2]. The variable regions f this antibody have been cloned and, after verifying their antigen binding activity, expressed in general 
purpose vectors forthe intracellular expression of a tibodies. The results confirmed that the cloned antibody has been efficiently expressed both 
in the secretory and the intracellular forms. Thus, intracellular immunization of mammalian cells against p21 ras, or any other antigen for which 
a monoclonal antibody is available, can now be performed. 
Intracellular immunization; p2 lras rotein; Antibody expression vector 
1. INTRODUCTION 
Ras genes encode for membrane associated GTP-  
binding proteins that are involved in the control of  cell 
prol iferation and differentiation [3]. Members of  this 
gene family are highly conserved throughout evolution 
and are widely expressed in cells of  both lower and 
higher eukaryotes. All the available evidence points to 
ras proteins as key regulatory molecules linking growth 
factor receptors to their signal transduction pathway(s). 
In Saccharomyces cerevisiae a genetic approach has led 
to the identification of  functions for the RAS1 and 
RAS2 proteins as well as functions upstream and 
downstream of  the RAS gene products [4]. In mam- 
malian cells, where such an approach is not possible, 
the function of  ras gene products remains unclear. 
However,  microinjection of  the anti-p21 ras antibody 
Y13-259 [2] was shown to block the serum stimulated 
DNA synthesis in N IH  3T3 cells, the nerve growth fac- 
tor induced differentiation of  PC12 cells, the transfor- 
mat ion by a number o f  oncogenes as well as ras 
stimulated adenylate cyclase activity in yeast cells [3]. 
This antibody, therefore represents a valuable reagent 
to interfere with the function of  p21 ~as. However, the 
intrinsically transient nature o f  the antibody microin- 
jection experiments limits the usefulness o f  such an ap- 
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proach to study ras gene functions in mammal ian cells. 
We recently proposed the stable intracellular expression 
of  monoclonal  antibodies as a means to inactivate 
cellular proteins by demonstrating that heavy and light 
chains redirected to an intracellular compartment in- 
deed associate to form functional antibodies [1]. We 
report in this paper the molecular cloning of  the 
variable regions of  the heavy and light chain o f  the 
monoclonal  ant ibody Y13-259, and their reconstitution 
in general purpose vectors for extracellular and in- 
tracellular expression of  immunoglobulins in mam- 
malian cells. These constructs were transfected into 
cultured cells, confirming the subcellular localization of  
the expressed antibody chains. Experiments on in- 
tracellular immunization of  cells against the p21 ras pro- 
tein can therefore be performed. 
2. MATERIALS  AND METHODS 
2.1. Plasmids and bacterial strains 
MI3-VnPCR1, MI3-VKPCR1, pSV-gpt-Huvl and pSV-hyg-HuCr 
were a gift rom G. Winter (MRC Cambridge); plasmid p805 was 
received from M. Neuberger (MRC Cambridge) BW2029 bacteria (E. 
coli N6105 (Adhya Sankar, NIH) harbouring a temperature-sensitive 
),-repressor controlling expression of p21from pJCL-E30 [5]) were 
provided by B. Willumsen (University of Copenhagen). 
2.2. Cloning of immunoglobulin variable regions by PCR 
Total cytoplasmic RNA was prepared from Y13-259 hybridoma 
cells as descried [6]. First strand cDNA synthesis andPCR were per- 
formed as in [7], except that annealing w s carried out at 60°C. 
Abbreviations: PCR, polymerase chain reaction; NLS, nuclear 
localization sequence; FCS, fetal calf serum; BG, ~-globin-promoter; 
Vn, variable region of the heavy chain; VK,variable region f the light 
chain; HuC~:, constant regions of the human heavy ~-1 chain; HUCK, 
constant region f the human light x chain 
2.3. Plasmid and mutant construction 
The ~-globin promoter region was excised as a 850 bp Hin- 
dlll/Ncol fragment from p805 and cloned into MI3-VnPCRI and 
M13-VKPCRI [7], cut with HindlI1/NcoI, giving MI3-/3G-VHPCR 
and M 13-~G-VKPCR. The PCR amplified DNA was force cloned into 
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Secruence  o f  Y13-259 V H 
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1 i0 20 
Q V Q L Q Q S G G G L V Q P G R S L K L 
CAG GTC CAA CTG CAG CAG TCT GGA GGA GGC TTA GTG CAG CCT GGA AGG TCC CTG AAA CTC 
Ps t l  
21 30 GDRI  40 
S C V V S G F T F S N Y G M N W I R Q T 
TCC TGT GTA GTC TCT GGA TTC ACT TTC AGT AAC TAT GGA ATG AAC TGG ATT  CGC CAG ACT 
50 52 A CDR2 
P G K G L E W V A Y I S S G S S Y L Y Y. 
CCA GGG AAG GGA CTG GAG TGG GTT GCA TAC ATT  AGT AGT GGT AGC AGT TAC CTC TAC TAT 
60 70 
A E T V K G R F T I S R D N A K N T L Y 
GCA GAA ACG GTG AAG GGC CGA TTC ACC ATC TCC AGA GAC AAT GCC AAG AAC ACC CTG TAC 
80 82 A B C 90 
L Q M T S L R S E D T A L Y Y C A R H E. 
CTG CAA ATG ACC AGT CTG AGG TCT GAA GAC ACT GCC TTG TAT TAC TGT GCA AGA CAT GAG 
GDR$ 1OO A B G 
G T G T D F F D Y W G Q G T T V T V S S 
GGT ACG GGT ACC GAC TTC TTT GAT TAC TGG GGC CAA GGG ACC ACG GTC ACC GTC TCC TCA 
Bst  E 
B Seuuence  of Y13-259  V K 
1 i0 20 
D I Q L T Q S P H S L S A S L G E T V S 
GAC ATC CAG CTG ACC CAG TCT CCA CAT TCC CTG TCT GCA TCT CTG GGA GAA ACT GTC TCC 
Pvu I I  
CDRI  30 40 
I E C L A S E G I S N Y L A W Y Q Q K P 
ATC GAA TGT CTA GCA AGT GAG GGC ATT  TCC AAT TAT TTA GCG TGG TAT CAG CAG AAG CCA 
$0 GDR2 60 
G K S P Q L L I Y Y A S S L Q D G V P S 
GGG AAA TCT CCT CAG CTC CTG ATC TAT TAT GCA AGT AGC TTG CAA GAT GGG GTC CCA TCA 
70 80 
R F S G S G S G T Q F S L K I S N M Q P 
CGG TTC AGT GGC AGT GGA TCT GGC ACA CAG TTT TCT CTC AAG ATC AGC AAC ATG CAA CCT 
90 CDR3 i00 
E D E G V Y Y C Q Q A Y K Y P S T F G A 
GAA GAT GAA GGG GTT TAT TAC TGT CAA CAG GCT TAC AAG TAT CCT TCC ACG TTT  GGA GCT 
G T K L E I K 
GGG ACC AAG CTG GAG ATC AAA 
<Bgl I I /Bc l I>  
Fig. 1. Nucleotide and amino acid sequence of Y 13-259 heavy (A) and light (B) variable regions. The PCR primers and the adjacent flanking regions 
are underlined. 
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these M13 vectors [7], giving M13-/3G-VH259 and M13-/3G-VK259 
(Fig. 4), and subsequently sequenced [8]. The HindlIl/BamHl 
fragments from these vectors were recloned in the modified pSV-gpt 
and pSV-hyg vectors [7], giving p/3G-VH259 and p/3G-VK259. 
The secretory leader sequence from the mouse V47 Via gene [9] 
utilized in the MI3-PCR vectors was substituted by the nuclear 
localization sequence (NLS) as described [3] giving the M 13-/3G/NLS- 
VH259 and M13-/3G/NLS-VK259 (Fig. 4). HindlII/BamHI fragments 
from these plasmids were then inserted into the pSV-gpt and pSV-hyg 
expression vectors, giving p/3G/NLS-VH259 and p/3G/NLS-Vk259. 
2.4. Cells, transfections, immunofluorescence and Western blot 
Rat pituitary GH3 [10] and simian COS cells were cultured in 
DMEM with 10070 FCS and transfected by DEAE-dextrane/chloro- 
quine [11]. Indirect immunofluorescence was performed as described 
in [1]. Expression of the p21 ras protein in BW2029 exponentially 
growing at 30°C was induced overnight at 42°C and harvested as 
described [5]. The p21 ras protein was revealed by Western blotting [5]. 
3. RESULTS 
The variable regions of  the heavy and light chain of  
the rat monoclonal  ant ibody Y13-259 [2] were cloned 
by the polymerase chain reaction (PCR) method, as 
recently described [7]. The sequences were confirmed 
on different clones obtained from independent 
amplif ication reactions. Fig. 1 shows the nucleotide se- 
quence of the heavy and light chain variable regions, 
between the two amplif ication primers (underlined), 
together with the deduced amino acid sequence. The 
amino acid sequences corresponding to the regions of  
the PCR primers are likely to differ in Y13-259. The 
complementarity determining regions (CDR) are 
overlined. Inspection of  the Kabat data base showed 
that the sequences obtained are different from all other 
immunoglobul in variable regions. 
The VH and VK gene regions of  Y13-259 antibody 
were assembled together with human C7 and CK genes 
respectively, in vectors for expression of  secreted 
ra t /human chimaeric antibodies, pI3G-Vn259 and p/3G- 
Vr259. Cotransfection of  these constructs into the cell 
lines COS and GH3 gave rise to high expression of  the 
corresponding antibody chains. Fig. 2 shows correspon- 
ding fields of  COS cell transfectants stained by double 
indirect immunofluorescence for light (Fig. 2A) and 
heavy (Fig. 2B) chain. Both double positive and single 
positive cells are present in the cell population. The 
staining pattern is typical of  a secretory protein. 
The supernatant of  the COS double transfectants was 
assayed by Western blotting for the production of  anti- 
p21 *as antibodies (Fig. 3). The experiment demonstrates 
that these cells indeed secrete, albeit in low amounts,  
antibodies that recognize p21 *as protein (Fig. 3, lane 3) 
as do the parental Y13-259 antibodies (Fig. 3, lane 1). 
The secretory form of  the cloned Y13-259 antibody is 
unlikely to interact with its corresponding antigen 
p21 ras inside the cell, due to their different intracellular 
localization. In order to redirect the antibody away 
f rom the secretory pathway, the hydrophobic ore of  
the secretory leader was substituted with the nuclear 
localization signal PKKKRKV from the SV40 large T 
Fig. 2. Coexpression of secretory heavy nd light chains from Y 13-259 
in COS cells transfected with pbG-Vn259 and pbG-VK259.48 h after 
transfection cells were stained by double indirect immunofluorescence 
with anti-light chain (A) and anti-heavy chain (B) antibodies. The 
same field is shown for the two fluorochromes used. 
I 2 3 4 5 6 
30.0 " 
- !4  iii:   21.0 ,~ 
W .... 
Fig. 3. Western blot analysis of COS cell transfectants. Cell extracts 
from heat shock induced (lanes 1, 3, 5) or uninduced (lanes 2, 4, 6) 
BW2029 bacteria were probed after SDS-PAGE with Y13-259 an- 
tibodies (lanes 1, 2) and with supernatant from COS cells transiently 
transfected with p~G-VH259 and p/3G-VK259 (lanes 3, 4) or with cor- 
responding plasmids encoding a non-relevant antibody (lanes 5, 6). 
The molecular size markers are indicated with arrows as well as the 
position of bacterial produced p21; Mw approx. 23 kDa. 
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Fig. 4. Shuttle vectors for expression f immunoglobulin genes. The amino acid sequences of the wild-type secretory leader and of the nuclear 
localization leader are shown. The Y13-259 sequences (hatched boxes) and the adjacent flanking regions (unfilled boxes) correspond to the se- 
quences shown in Fig. 1. The lines represent the leader intron and part of the V-C intron. Any variable region amplified with the primers described 
in [11] can be cloned into these vectors. H = Hindl I I ;  N =Nco l ;  P = Pst l ;  BE = BstEI I ;  B = BamH1;  R = Pvul I ;  X = Bc l I /Bg l l I  (the BclI 
site in the parental vector is l st upon cloning). 
antigen [12] (Fig. 4), which we have shown directs im- 
munoglobulin chains away from the secretory pathway 
and to the cytoplasm, from where, in some cell types, 
they reach the nucleus [1]. The NLS was incorporated 
into M 13-~G-V,-I259 and M 13-~G-VK259 (Fig. 4). After 
further cloning the activity of the final 'intracellular' 
expression vectors, p/~G/NLS-V,-I259 and p~G/NSL- 
VK259, was determined by immunofluorescence after 
transient ransfection into COS cells. Results for the 
heavy chain transfectants are shown in Fig. 5. Many 
cells in the transfected population show a bright signal 
for this antibody chain, demonstrating that this 
polypeptide chain are correctly and efficiently syn- 
thesized. The intracellular staining pattern (Fig. 
5C,D,E) was remarkably different from that obtained 
for the secretory antibody chains (Figs. 2 and 5A), in 
keeping with the engineered irection of the antibody 
chain away from the secretory compartment. Different 
staining patterns can be found in the cell population, 
ranging from a predominant nuclear staining (Fig. 5C) 
to stainings in which both the nucleus and the 
cytoplasm are labelled (Fig. 5D). Cells with only the 
cytoplasm labelled are also found (Fig. 5E). 
Qualitatively similar results are obtained for the light 
chain (not shown), although the intensity of the signal 
is lower. 
4. DISCUSSION 
We have recently demonstrated the feasibility of ex- 
pressing monoclonal antibodies in different in- 
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tracellular compartments to interfere with the function 
of selected intracellular antigens [1], as one possible 
strategy to achieve 'intracellular immunization' [13] in 
mammalian cells. As a first application of this ex- 
perimental strategy, we undertook experiments o per- 
turb the function of the protooncogene c-ras. The 
monoclonal antibody Y13-259 is able to neutralize c- 
and v-ras activity following microinjection i to living 
cells. We have therefore cloned the variable regions of 
this antibody and confirmed the antigen binding activi- 
ty of the reconstituted secretory antibody by assaying 
the supernatants of transiently transfected COS ceils. 
The cloned antibody does indeed recognize specifically 
p21 ras protein, as the parental antibody (Fig. 3). The 
levels of antibodies ecreted by COS cell transfectants 
appear to be quite low, possibly due to (i) the small 
percentage of the cells in the transfected population ex- 
pressing the antibodies, and (ii) the reported low effi- 
ciency of antibody secretion by COS cells and other 
fibroblast cell lines [14]. We are presently deriving 
stable cell lines (NSO myeloma nd GH3 pituitary cells) 
secreting the r combinant Y13-259 antibody (work in 
progress). We then engineered general purpose vectors 
for the intracellular expression of any antibody of in- 
terest. The results obtained confirm that the cloned an- 
tibody has been successfully expressed both in the 
secretory and the intracellular versions. It is noteworthy 
that the levels of expression of the intracellular heavy 
chain are comparable to its secretory counterpart (Fig. 
5). We further show that the nuclear localization se- 
quence (NLS) has proven efficient also for the heavy 




!! ~ i  ¸  
Fig. 5. Cellular distribution of the secretory (A) and intracellular (C, D and E) Y13-259 recombinant heavy chain. COS cells were transfected with 
p~G-VH259 and p~G/NLS-Vn259 and stained 48 h later with anti-heavy chain antibodies. B and F show phase contrast pictures of the fields in 
A and E, respectively. 
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chain, as previously reported for the light chain [1], 
both in terms of preventing secretion, expression levels 
and targeting to the nucleus (Fig. 5). The fluorescence 
signal obtained for the light chain is somewhat lower, 
possibly due to cleavage of the constant domain or 
masking by some intracellular protein. This is consis- 
tent with our previous finding [1] that probing for in- 
tracellular antibodies with anti-idiotypic antibodies 
gives a higher proportion of nuclear labelling than pro- 
bing with anti-isotype antibodies. The presence of the 
NLS targeting signal on the anti-p21 ras antibody might 
divert the p21 ras protein from its normal localization, 
thus contributing to inhibit its function. 
The results presented show that the general purpose 
vectors engineered for intracellular expression of an- 
tibodies perform very efficiently and can therefore be 
utilized to study the phenotype resulting from the ex- 
pression of any antibody of interest, in different cell 
types. In particular, it is now possible to derive cell lines 
in which the function of the p21 ras protein is inhibited, 
thereby allowing the study of its role(s) in different 
physiological and pathological contexts. 
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